Inflammatory changes in tumour vessels after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.
D000818:Animals; D001808:Blood Vessels / Q000473:pathology*; D001920:Bradykinin / Q000494:pharmacology*; D006528:Carcinoma, Hepatocellular / Q000473:pathology*; D007610:Kallikreins / Q000494:pharmacology*; D008113:Liver Neoplasms; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D009374:Neoplasms, Experimental / Q000473:pathology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*
D008244:Lysophosphatidylcholines; D012701:Serotonin; D007610:Kallikreins; D001920:Bradykinin